Astec LifeSciences Ltd Q1 FY2023 consolidated net profit falls to Rs. 11.39 crores

Astec LifeSciences Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 186.9767 crores during the period ended June 30, 2022 as compared to Rs. 278.7868 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 11.3999 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 43.0546 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 5.81 for the period ended June 30, 2022 as compared to Rs. 21.96 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 186.9767 crs	₹278.7868 crs	-32.93%
Net Profit	₹11.3999 crs	₹43.0546 crs	-73.52%
EPS	₹5.81	₹21.96	-73.54%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 186.9767 crores during the period ended June 30, 2022 as compared to Rs.129.4604 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.11.3999 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.12.9848 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.5.81 for the period ended June 30, 2022 as compared to Rs.6.62 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 186.9767 crs	₹129.4604 crs	44.43%
Net Profit	₹11.3999 crs	₹12.9848 crs	-12.21%
EPS	₹5.81	₹6.62	-12.24%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1934.15 as compared to the previous close of Rs. 2009.85. The total number of shares traded during the day was 4796 in over 1181 trades.

The stock hit an intraday high of Rs. 2080.00 and intraday low of 1930.20. The net turnover during the day was Rs. 9447464.00.

Source : Equity Bulls

Keywords

AstecLifeSciences Q1FY23 ResultUpdate